Liquidia Corp (LQDA) stock
LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.73+0.36 (+0.64%)
Close on Nov 17, 2026Market cap $5.08BP/E 40.8Yield –
Liquidia ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Liquidia's ebitda for the twelve months ending Jun 30, 2026 was $169.99M. For fiscal 2025 it was -$49.85M. The highest annual figure on record is -$28.19M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$49.85M | – |
| FY2024 | Dec 31, 2024 | -$119.10M | – |
| FY2023 | Dec 31, 2023 | -$71.21M | – |
| FY2022 | Dec 31, 2022 | -$35.12M | – |
| FY2021 | Dec 31, 2021 | -$28.19M | – |
| FY2020 | Dec 31, 2020 | -$55.96M | – |
| FY2019 | Dec 31, 2019 | -$44.26M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $85.82M | – |
| Q1 FY2026 | Mar 31, 2026 | $62.00M | – |
| Q4 FY2025 | Dec 31, 2025 | $20.11M | – |
| Q3 FY2025 | Sep 30, 2025 | $2.07M | – |
| Q2 FY2025 | Jun 30, 2025 | -$37.31M | – |
| Q1 FY2025 | Mar 31, 2025 | -$34.97M | – |
| Q4 FY2024 | Dec 31, 2024 | -$35.59M | – |
| Q3 FY2024 | Sep 30, 2024 | -$28.89M | – |
| Q2 FY2024 | Jun 30, 2024 | -$27.00M | – |
| Q1 FY2024 | Mar 31, 2024 | -$28.31M | – |
| Q4 FY2023 | Dec 31, 2023 | -$25.93M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.59M | – |
| Q2 FY2023 | Jun 30, 2023 | -$22.53M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.66M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.93M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.43M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.57M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.53M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.49M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.68M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.95M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.39M | – |
| Q4 FY2020 | Dec 31, 2020 | -$14.96M | – |
| Q3 FY2020 | Sep 30, 2020 | -$14.09M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.77M | – |
| Q1 FY2020 | Mar 31, 2020 | -$13.91M | – |
See a number that looks wrong?